Aktis Oncology, Inc.

AKTS Nasdaq Healthcare · Pharmaceutical Preparations Boston, MA www.aktisoncology.com/
$16.11
Mkt Cap 868.5M

Biotechnology company developing alpha-particle radiopharmaceuticals (radioactive cancer drugs) for cancer treatment; no approved products yet.

—
/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
Running full 6-factor analysis…